Skip to main content
EMV CAPITAL PLC logo

EMV CAPITAL PLC — Investor Relations & Filings

Ticker · EMVC ISIN · GB00BN4R5Q82 LEI · 213800N5WD46G1Y7I458 IL Financial and insurance activities
Open in API
Filings indexed 547 across all filing types
Latest filing 2018-03-13 Regulatory Filings
Country GB United Kingdom
Listing IL EMVC

About EMV CAPITAL PLC

https://www.emvcapital.com/

EMV Capital PLC is a venture capital investment group specializing in deep tech and life sciences. The firm identifies, invests in, and builds high-growth, IP-rich companies with an international portfolio, focusing on sectors including industrial technology, healthcare, and sustainability. It employs a capital-efficient investment strategy that combines syndicated investments, direct balance sheet funding, and managed funds to support companies from their early stages through to successful exit. EMV Capital engages in proactive portfolio management, often taking board positions and working closely with company leadership. It provides extensive value creation services, including support for fundraising, exit readiness, IP strategy, and corporate collaborations, to drive growth and maximize returns for investors through strategic exits.

Recent filings

Filing Released Lang Actions
Vortex Announces Partnership with BioView
Regulatory Filings Classification · 100% confidence The document is a press release issued via the Regulatory News Service (RNS) of the London Stock Exchange. It announces a business collaboration between NetScientific's subsidiary, Vortex Biosciences, and BioView Ltd. Since this is a general corporate announcement regarding a partnership and does not fit into specific categories like financial reports, M&A, or director dealings, it falls under the RNS regulatory filing category.
2018-03-13 English
Jahresabschluss zum Geschäftsjahr vom 01.01.2016 bis zum 31.12.2016
Audit Report / Information Classification · 98% confidence The document is a 'Jahresabschluss' (Annual Financial Statement) for the fiscal year 2016, including a balance sheet (Bilanz) and notes (Anhang) prepared under the German Commercial Code (HGB). While it is a financial report, it is not a full 10-K (which is a specific US SEC filing format). Given the definitions provided, it functions as a comprehensive annual financial report for a private entity, which aligns best with the '10-K' category as the standard for annual financial performance reporting in this taxonomy. FY 2016
2018-03-01 German
ProAxsis Reports First NEATstik Sale
Regulatory Filings Classification · 98% confidence The document is an RNS (Regulatory News Service) announcement from the London Stock Exchange regarding a commercial update for NetScientific PLC's portfolio company, ProAxsis. It details a specific business milestone (the first sale of a product) rather than a formal financial report, audit, or governance document. As it is a general regulatory announcement that does not fit into more specific categories like M&A or share issues, it is classified as a Regulatory Filing (RNS).
2018-02-15 English
Vortex Releases Publication in Nature Scientific
Regulatory Filings Classification · 98% confidence The document is an RNS (Regulatory News Service) announcement from NetScientific PLC regarding a scientific publication by its subsidiary, Vortex BioSciences. It describes the publication of a peer-reviewed report in 'Nature Scientific Reports' and provides a link to the external study. It does not constitute a financial report, audit, or governance document itself, but rather serves as a corporate news announcement regarding external research activities. As it is a general regulatory announcement that does not fit into specific financial categories like 10-K or IR, it is classified as a Regulatory Filing (RNS).
2018-02-09 English
NetScientific Portfolio Update
Regulatory Filings Classification · 98% confidence The document is an RNS (Regulatory News Service) announcement from NetScientific PLC providing a portfolio update on its various subsidiary companies (Glycotest, Vortex, ProAxsis, etc.). It details operational progress, clinical trial updates, and future financing targets. As it is a general regulatory announcement regarding company operations and business updates that does not fit into specific categories like financial reports or dividend notices, it is classified as a Regulatory Filing (RNS).
2018-01-16 English
PDS Announces Clinical Collaboration with Merck
Regulatory Filings Classification · 98% confidence The document is a regulatory announcement (RNS) issued by NetScientific PLC regarding a clinical trial collaboration between its portfolio company, PDS Biotechnology, and Merck & Co. It provides details on a business development/partnership event. Since it is a general corporate announcement regarding company news that does not fit into specific categories like M&A (which usually implies a takeover or merger) or financial reporting, it falls under the RNS (Regulatory Filings) category as a general corporate update.
2017-07-10 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.